Variable | No. of patients | Over survival | P |
---|---|---|---|
Median ± SE | |||
Cytogenetics | Â | Â | Â |
Favorable | 50 | 46.664 ± 3.717 | <0.001 |
Intermediate | 27 | 29.220 ± 3.188 |  |
Unfavorable | 28 | 11.161 ± 1.827 |  |
FAB | Â | Â | Â |
M1-M6 | 93 | 36.113 ± 2.885 | <0.001 |
M7 | 12 | 8.542 ± 1.820 |  |
Leukocyte (/μl) |  |  |  |
>10000 | 61 | 30.220 ± 2.974 | 0.803 |
≤10000 | 44 | 33.631 ± 4.063 |  |
MRD | Â | Â | Â |
<0.25% | 49 | 53.627 ± 3.151 | <0.001 |
≥0.25% | 56 | 18.893 ± 2.425 |  |
EBF3 expression | Â | Â | Â |
Low < 12.11 | 52 | 38.971 ± 4.402 | 0.091 |
High ≥ 12.11 | 53 | 32.864 ± 3.654 |  |
EBF3 methylation | Â | Â | Â |
Negative | 60 | 35.143 ± 3.509 | 0.190 |
Positive | 45 | 29.458 ± 2.607 |  |